Targeted exosome precision medicine company
Employees: 1-10
Founded date: 2021
Investors 1
| Date | Name | Website |
| 19.03.2022 | Northern L... | nlvc.com |
Mentions in press and media 3
| Date | Title | Description |
| 10.04.2024 | Development of exosome therapy to treat inflammatory bowel disease by VesiCURE Therapeutics | SUZHOU, China, April 10, 2024 /PRNewswire/ -- IBD, or Inflammatory Bowel Disease, traditionally more prevalent in developed nations, is increasingly observed in developing regions like China. It is a chronic, nonspecific inflammatory gastro... |
| 29.01.2024 | Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation | SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- SiRNA technology offers distinct advantages over conventional approaches, with the potential to target virtually any gene. This technology has emerged as a great strategy for treating a range of ... |
| 05.09.2023 | Exosomes functionally deliver siRNAs in vivo to repress tumor growth | SUZHOU, China, Sept. 5, 2023 /PRNewswire/ -- VesiCURE Therapeutics Co. Ltd., a biotechnology company located in Suzhou, China, recently released a preprint on BioRxiv titled "Harnessing extracellular vesicles for efficient siRNA delive... |